130 related articles for article (PubMed ID: 12210763)
1. Differential effects of iron deficiency on the expression of CD80 and CD86 co-stimulatory receptors in mitogen-treated and untreated murine spleen cells.
Kuvibidila SR; Porretta C
J Cell Biochem; 2002; 86(3):571-82. PubMed ID: 12210763
[TBL] [Abstract][Full Text] [Related]
2. In vivo and in vitro iron deficiency reduces protein kinase C activity and translocation in murine splenic and purified T cells.
Kuvibidila SR; Kitchens D; Baliga BS
J Cell Biochem; 1999 Sep; 74(3):468-78. PubMed ID: 10412047
[TBL] [Abstract][Full Text] [Related]
3. Effects of iron deficiency on the secretion of interleukin-10 by mitogen-activated and non-activated murine spleen cells.
Kuvibidila S; Yu L; Ode D; Velez M; Gardner R; Warrier RP
J Cell Biochem; 2003 Oct; 90(2):278-86. PubMed ID: 14505344
[TBL] [Abstract][Full Text] [Related]
4. Iron deficiency and in vitro iron chelation reduce the expression of cluster of differentiation molecule (CD)28 but not CD3 receptors on murine thymocytes and spleen cells.
Kuvibidila SR; Porretta C
Br J Nutr; 2003 Jul; 90(1):179-89. PubMed ID: 12844390
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory action of a macrolide antibiotic, roxithromycin, on co-stimulatory molecule expressions in vitro and in vivo.
Suzuki M; Asano K; Yu M; Hisamitsu T; Suzaki H
Mediators Inflamm; 2002 Aug; 11(4):235-44. PubMed ID: 12396475
[TBL] [Abstract][Full Text] [Related]
6. Iron deficiency, but not underfeeding reduces the secretion of interferon-gamma by mitogen-activated murine spleen cells.
Kuvibidila SR; Gardner R; Velez M; Yu L
Cytokine; 2010 Dec; 52(3):230-7. PubMed ID: 20850986
[TBL] [Abstract][Full Text] [Related]
7. CTLA4-CD80/CD86 interactions on primary mouse CD4+ T cells integrate signal-strength information to modulate activation with Concanavalin A.
Mukherjee S; Ahmed A; Nandi D
J Leukoc Biol; 2005 Jul; 78(1):144-57. PubMed ID: 15788440
[TBL] [Abstract][Full Text] [Related]
8. Iron deficiency reduces serum and in vitro secretion of interleukin-4 in mice independent of altered spleen cell proliferation.
Kuvibidila SR; Velez M; Gardner R; Penugonda K; Chandra LC; Yu L
Nutr Res; 2012 Feb; 32(2):107-15. PubMed ID: 22348459
[TBL] [Abstract][Full Text] [Related]
9. Interferon-beta up-regulates the expression of co-stimulatory molecules CD80, CD86 and CD40 on monocytes: significance for treatment of multiple sclerosis.
Marckmann S; Wiesemann E; Hilse R; Trebst C; Stangel M; Windhagen A
Clin Exp Immunol; 2004 Dec; 138(3):499-506. PubMed ID: 15544628
[TBL] [Abstract][Full Text] [Related]
10. Aneuploidy assessed by DNA index influences the effect of iron status on plasma and/or supernatant cytokine levels and progression of cells through the cell cycle in a mouse model.
Kuvibidila S; Porretta C; Baliga S
Cytokine; 2014 Feb; 65(2):175-83. PubMed ID: 24374092
[TBL] [Abstract][Full Text] [Related]
11. Administration of dendritic cells transduced with antisense oligodeoxyribonucleotides targeting CD80 or CD86 prolongs allograft survival.
Liang X; Lu L; Chen Z; Vickers T; Zhang H; Fung JJ; Qian S
Transplantation; 2003 Aug; 76(4):721-9. PubMed ID: 12973117
[TBL] [Abstract][Full Text] [Related]
12. Co-stimulation with 4-1BB ligand allows extended T-cell proliferation, synergizes with CD80/CD86 and can reactivate anergic T cells.
Habib-Agahi M; Phan TT; Searle PF
Int Immunol; 2007 Dec; 19(12):1383-94. PubMed ID: 17977894
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of murine corneal allograft rejection by treatment with antibodies to CD80 and CD86.
Kagaya F; Hori J; Kamiya K; Kaji Y; Oshika T; Amano S; Yamagami S; Tsuru T; Tanaka S; Matsuda H; Yagita H; Okumura K
Exp Eye Res; 2002 Jan; 74(1):131-9. PubMed ID: 11878826
[TBL] [Abstract][Full Text] [Related]
14. Iron deficiency alters the progression of mitogen-treated murine splenic lymphocytes through the cell cycle.
Kuvibidila SR; Porretta C; Baliga BS
J Nutr; 2001 Jul; 131(7):2028-33. PubMed ID: 11435525
[TBL] [Abstract][Full Text] [Related]
15. Chronic ethanol ingestion by mice increases expression of CD80 and CD86 by activated macrophages.
Zhu X; Coleman RA; Alber C; Ballas ZK; Waldschmidt TJ; Ray NB; Krieg AM; Cook RT
Alcohol; 2004 Feb; 32(2):91-100. PubMed ID: 15163560
[TBL] [Abstract][Full Text] [Related]
16. The role of B7 ligands (CD80 and CD86) in CD152-mediated allograft tolerance: a crosscheck hypothesis.
Tsai MK; Ho HN; Chien HF; Ou-Yang P; Lee CJ; Lee PH
Transplantation; 2004 Jan; 77(1):48-54. PubMed ID: 14724434
[TBL] [Abstract][Full Text] [Related]
17. Evidence for the involvement of T cell costimulation through the B-7/CD28 pathway in atherosclerotic plaques from apolipoprotein E knockout mice.
Afek A; Harats D; Roth A; Keren G; George J
Exp Mol Pathol; 2004 Jun; 76(3):219-23. PubMed ID: 15126104
[TBL] [Abstract][Full Text] [Related]
18. VIP/PACAP oppositely affects immature and mature dendritic cell expression of CD80/CD86 and the stimulatory activity for CD4(+) T cells.
Delgado M; Reduta A; Sharma V; Ganea D
J Leukoc Biol; 2004 Jun; 75(6):1122-30. PubMed ID: 15020654
[TBL] [Abstract][Full Text] [Related]
19. Proteoglycan isolated from Phellinus linteus activates murine B lymphocytes via protein kinase C and protein tyrosine kinase.
Kim GY; Park SK; Lee MK; Lee SH; Oh YH; Kwak JY; Yoon S; Lee JD; Park YM
Int Immunopharmacol; 2003 Sep; 3(9):1281-92. PubMed ID: 12890426
[TBL] [Abstract][Full Text] [Related]
20. Expression of costimulatory molecules (CD80, CD86, CD28, CD152), accessory molecules (TCR alphabeta, TCR gammadelta) and T cell lineage molecules (CD4+, CD8+) in PBMC of leprosy patients using Mycobacterium leprae antigen (MLCWA) with murabutide and T cell peptide of Trat protein.
Sridevi K; Neena K; Chitralekha KT; Arif AK; Tomar D; Rao DN
Int Immunopharmacol; 2004 Jan; 4(1):1-14. PubMed ID: 14975355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
